Literature DB >> 17205058

Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor alpha-chain predicts a poor prognosis.

K Nakase1, K Kita, H Miwa, K Nishii, M Shikami, I Tanaka, H Tsutani, T Ueda, K Nasu, T Kyo, H Dohy, H Shiku, N Katayama.   

Abstract

We quantitatively assessed the expression of cytokine receptors (interleukin-2 receptor (IL-2R), IL-3R, IL-4R, IL-5R, IL-6R, IL-7R, granulocyte-macrophage colony-stimulating factor R (GM-CSFR), G-CSFR, c-fms, c-mpl, c-kit and FLT3) in cells from 211 adults with acute lymphoblastic leukemia (ALL) by flow cytometry and determined their prevalence and clinical significance. Although all cytokine receptors were expressed to various degrees, the levels of IL-3R alpha-chain (IL-3Ralpha), IL-2Ralpha, IL-2Rbeta, IL-7Ralpha, common-Rgamma(gammac), c-mpl, c-kit and FLT3 exhibited a wide spectrum > or =2000 sites/cell. Among them, IL-3Ralpha, IL-2Ralpha and FLT3 were highly expressed in B-lineage ALL, whereas IL-7Ralpha, gammac and c-kit predominated in T-lineage ALL. Higher levels of IL-3Ralpha, IL-2Ralpha, c-kit and FLT3 correlated with the expression of CD13/33. Increased IL-2Ralpha levels related to the presence of Philadelphia chromosome (Ph), leukocytosis and shorter event-free survival (EFS). C-kit preferred in male. Elevated FLT3 levels correlated with age > or =60 years. Multivariate analysis in B-lineage ALL revealed only IL-2Ralpha (P=0.028) and Ph (P=0.020) as independent factors for EFS. These findings suggest that several cytokine receptors associated with certain cellular and clinical features, but IL-2Ralpha solely had a prognostic value and should be considered as a major prognostic factor for adult ALL that is comparable with Ph.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205058     DOI: 10.1038/sj.leu.2404497

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  11 in total

1.  Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors.

Authors:  Jesse Jaso; Deborah A Thomas; Krista Cunningham; Jeffrey L Jorgensen; Hagop M Kantarjian; L Jeffrey Medeiros; Sa A Wang
Journal:  Cancer       Date:  2011-03-01       Impact factor: 6.860

2.  Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia.

Authors:  Amos S Gaikwad; Rachel E Donohue; M Tarek Elghetany; Andrea M Sheehan; Xinyan Y Lu; Maria M Gramatges; Kenneth L McClain; Toni-Ann Mistretta; Jyotinder N Punia; Timothy J Moore; Tatiana Goltsova; Michael Cubbage; Choladda V Curry
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 3.  Common gamma chain cytokines in combinatorial immune strategies against cancer.

Authors:  Stephanie R Pulliam; Roman V Uzhachenko; Samuel E Adunyah; Anil Shanker
Journal:  Immunol Lett       Date:  2015-11-17       Impact factor: 3.685

4.  Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.

Authors:  Kazunori Nakase; Kenkichi Kita; Taiichi Kyo; Takanori Ueda; Isao Tanaka; Naoyuki Katayama
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

5.  Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease.

Authors:  Masahiro Yasunaga; Shino Manabe; Yasuhiro Matsumura
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

Review 6.  Pediatric precursor B acute lymphoblastic leukemia: are T helper cells the missing link in the infectious etiology theory?

Authors:  Simone Bürgler; David Nadal
Journal:  Mol Cell Pediatr       Date:  2017-05-16

7.  A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease.

Authors:  Chao Liu; Bing Sun; Bin Xu; Xiangying Meng; Lan Li; Yang Cong; Jiannan Liu; Qian Wang; Liang Xuan; Qibin Song; Shikai Wu
Journal:  Cancer Manag Res       Date:  2018-06-26       Impact factor: 3.989

8.  Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine.

Authors:  P Miltiades; E Lamprianidou; T P Vassilakopoulos; S G Papageorgiou; A G Galanopoulos; S Vakalopoulou; V Garypidou; M Papaioannou; E Hadjiharissi; V Pappa; H A Papadaki; E Spanoudakis; K Tsatalas; I Kotsianidis
Journal:  Blood Cancer J       Date:  2014-02-28       Impact factor: 11.037

9.  Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients.

Authors:  Chao Liu; Wei Wang; Xiangying Meng; Bing Sun; Yang Cong; Jiannan Liu; Qian Wang; Guangxian Liu; Shikai Wu
Journal:  Onco Targets Ther       Date:  2018-04-12       Impact factor: 4.147

10.  Prognostic value of CD25/CD123 pattern of expression in acute myeloid leukemia patients with normal cytogenetic.

Authors:  Salah Aref; Emaad Azmy; Lamiaa Ibrahim; Mohamed Sabry; Mohamed El Agdar
Journal:  Leuk Res Rep       Date:  2020-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.